Targeting Histone Methylation to Reprogram the Transcriptional State That Drives Survival of Drug-Tolerant Myeloid Leukemia Persisters

The authors demonstrated that the anthracycline doxorubicin epigenetically reprogrammed leukemia cells by inducing histone 3 lysine 27 (H3K27) and H3K4 tri-methylation.